1. Home
  2. ULY vs INDP Comparison

ULY vs INDP Comparison

Compare ULY & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • INDP
  • Stock Information
  • Founded
  • ULY 2013
  • INDP 2000
  • Country
  • ULY United States
  • INDP United States
  • Employees
  • ULY N/A
  • INDP N/A
  • Industry
  • ULY
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • INDP Health Care
  • Exchange
  • ULY Nasdaq
  • INDP Nasdaq
  • Market Cap
  • ULY 14.8M
  • INDP 15.4M
  • IPO Year
  • ULY N/A
  • INDP N/A
  • Fundamental
  • Price
  • ULY $0.61
  • INDP $1.12
  • Analyst Decision
  • ULY Strong Buy
  • INDP Strong Buy
  • Analyst Count
  • ULY 1
  • INDP 1
  • Target Price
  • ULY $2.00
  • INDP $12.00
  • AVG Volume (30 Days)
  • ULY 586.3K
  • INDP 20.6K
  • Earning Date
  • ULY 11-12-2024
  • INDP 11-04-2024
  • Dividend Yield
  • ULY N/A
  • INDP N/A
  • EPS Growth
  • ULY N/A
  • INDP N/A
  • EPS
  • ULY 7.76
  • INDP N/A
  • Revenue
  • ULY $165,727,000.00
  • INDP N/A
  • Revenue This Year
  • ULY N/A
  • INDP N/A
  • Revenue Next Year
  • ULY $20.40
  • INDP N/A
  • P/E Ratio
  • ULY $0.08
  • INDP N/A
  • Revenue Growth
  • ULY N/A
  • INDP N/A
  • 52 Week Low
  • ULY $0.60
  • INDP $1.03
  • 52 Week High
  • ULY $12.00
  • INDP $3.25
  • Technical
  • Relative Strength Index (RSI)
  • ULY 28.07
  • INDP 34.05
  • Support Level
  • ULY $0.65
  • INDP $1.10
  • Resistance Level
  • ULY $0.72
  • INDP $1.22
  • Average True Range (ATR)
  • ULY 0.07
  • INDP 0.12
  • MACD
  • ULY -0.00
  • INDP 0.00
  • Stochastic Oscillator
  • ULY 5.22
  • INDP 16.20

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: